223 related articles for article (PubMed ID: 29728583)
1. LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors.
Arunkumar G; Anand S; Raksha P; Dhamodharan S; Prasanna Srinivasa Rao H; Subbiah S; Murugan AK; Munirajan AK
Sci Rep; 2018 May; 8(1):7018. PubMed ID: 29728583
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p.
Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L
J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p.
Wang M; Sun X; Yang Y; Jiao W
Thorac Cancer; 2018 Aug; 9(8):939-949. PubMed ID: 29897167
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
[TBL] [Abstract][Full Text] [Related]
7. LncRNA OIP5-AS1 upregulates snail expression by sponging miR-34a to promote ovarian carcinoma cell invasion and migration.
Jiang X; Ye Z; Jiang Y; Yu W; Fang Q
Biol Res; 2020 Oct; 53(1):49. PubMed ID: 33092644
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.
Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S
Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA AFAP1-AS1/miR-320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance.
Yuan Z; Xiu C; Song K; Pei R; Miao S; Mao X; Sun J; Jia S
J Cell Mol Med; 2018 Sep; 22(9):4253-4262. PubMed ID: 29971915
[TBL] [Abstract][Full Text] [Related]
10. lncRNA OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit cell apoptosis through a mechanism involving miR-143-3p in cervical cancer.
Song L; Wang L; Pan X; Yang C
Braz J Med Biol Res; 2020; 53(1):e8883. PubMed ID: 31939597
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2.
Deng J; Deng H; Liu C; Liang Y; Wang S
Biomed Pharmacother; 2018 Feb; 98():102-110. PubMed ID: 29247949
[TBL] [Abstract][Full Text] [Related]
12. LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells.
Zou Y; Yao S; Chen X; Liu D; Wang J; Yuan X; Rao J; Xiong H; Yu S; Yuan X; Zhu F; Hu G; Wang Y; Xiong H
Eur J Cell Biol; 2018 Jun; 97(5):369-378. PubMed ID: 29773344
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
Zhang Z; Sun L; Zhang Y; Lu G; Li Y; Wei Z
J Cell Physiol; 2018 Nov; 233(11):8630-8638. PubMed ID: 29797562
[TBL] [Abstract][Full Text] [Related]
14. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR.
Kim J; Abdelmohsen K; Yang X; De S; Grammatikakis I; Noh JH; Gorospe M
Nucleic Acids Res; 2016 Mar; 44(5):2378-92. PubMed ID: 26819413
[TBL] [Abstract][Full Text] [Related]
15. LncRNA OIP5-AS1 aggravates the stemness of hepatoblastoma through recruiting PTBP1 to increase the stability of β-catenin.
Jiang W; Ou ZL; Zhu Q; Yao YB; Zai HY
Pathol Res Pract; 2022 Apr; 232():153829. PubMed ID: 35255389
[TBL] [Abstract][Full Text] [Related]
16. OIP5-AS1: A Fascinating Long Noncoding RNA in Carcinoma.
Zhong J; Chen J; Wang B; Zhou Z; Shen Y; Gong Y; Tan F; Yuan C
Curr Pharm Des; 2021; 27(46):4699-4706. PubMed ID: 34579624
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA OIP5-AS1 promotes the stemness of lung cancer cells through enhancing Oct4 mRNA stability.
Mao C; Li X
Environ Toxicol; 2022 May; 37(5):1104-1112. PubMed ID: 35044041
[TBL] [Abstract][Full Text] [Related]
18. A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies.
Ghafouri-Fard S; Dashti S; Farsi M; Hussen BM; Taheri M
Biomed Pharmacother; 2021 May; 137():111366. PubMed ID: 33601149
[TBL] [Abstract][Full Text] [Related]
19. LncRNA OIP5-AS1 inhibits osteoblast differentiation of valve interstitial cells via miR-137/TWIST11 axis.
Zheng D; Wang B; Zhu X; Hu J; Sun J; Xuan J; Ge Z
Biochem Biophys Res Commun; 2019 Apr; 511(4):826-832. PubMed ID: 30846207
[TBL] [Abstract][Full Text] [Related]
20. LncRNA OIP5-AS1/cyrano suppresses GAK expression to control mitosis.
Kim J; Noh JH; Lee SK; Munk R; Sharov A; Lehrmann E; Zhang Y; Wang W; Abdelmohsen K; Gorospe M
Oncotarget; 2017 Jul; 8(30):49409-49420. PubMed ID: 28472763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
